A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multicentre European hospital-based study
…, G Previtali, S van der Sar-Van Der Brugge… - Elife, 2020 - elifesciences.org
COVID-19 induces haemocytometric changes. Complete blood count changes, including new
cell activation parameters, from 982 confirmed COVID-19 adult patients from 11 European …
cell activation parameters, from 982 confirmed COVID-19 adult patients from 11 European …
A Tethered Ligand Assay to Probe the SARS-CoV-2 ACE2 Interaction under Constant Force (preprint)
…, H Ammerlaan, K Deiteren, SJL Bakker, LJ van Pelt… - 2020 - pesquisa.bvsalud.org
The current COVID-19 pandemic has a devastating global impact and is caused by the
SARS-CoV-2 virus. SARS-CoV-2 attaches to human host cells through interaction of its receptor …
SARS-CoV-2 virus. SARS-CoV-2 attaches to human host cells through interaction of its receptor …
Identification of TMEM106B as proviral host factor for SARS-CoV-2 (preprint)
…, H Ammerlaan, K Deiteren, SJL Bakker, LJ van Pelt… - 2020 - pesquisa.bvsalud.org
The ongoing COVID-19 pandemic is responsible for worldwide economic damage and nearly
one million deaths. Potent drugs for the treatment of severe SARS-CoV-2 infections are …
one million deaths. Potent drugs for the treatment of severe SARS-CoV-2 infections are …
No evidence that plasmablasts transdifferentiate into developing neutrophils in severe COVID-19 disease (preprint)
…, H Ammerlaan, K Deiteren, SJL Bakker, LJ van Pelt… - 2020 - pesquisa.bvsalud.org
A recent study by Wilk et al. of the transcriptome of peripheral blood mononuclear cells (PBMCs)
in seven patients hospitalized with COVID-19 described a population of'developing …
in seven patients hospitalized with COVID-19 described a population of'developing …
Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial
…, H Kieft, GH Kluge, VC van Dam, J van Pelt… - The Lancet Infectious …, 2016 - thelancet.com
Background In critically ill patients, antibiotic therapy is of great importance but long duration
of treatment is associated with the development of antimicrobial resistance. Procalcitonin is …
of treatment is associated with the development of antimicrobial resistance. Procalcitonin is …
[HTML][HTML] Clinical correlates of arterial lactate levels in patients with ST-segment elevation myocardial infarction at admission: a descriptive study
…, MWN Nijsten, IC van der Horst, LJ van Pelt… - Critical Care, 2010 - Springer
Introduction Blood lactate measurements can be used as an indicator of hemodynamic
impairment and relate to mortality in various forms of shock. Little is known at the moment …
impairment and relate to mortality in various forms of shock. Little is known at the moment …
[HTML][HTML] Risk factors for campylobacteriosis of chicken, ruminant, and environmental origin: a combined case-control and source attribution analysis
Background Campylobacteriosis contributes strongly to the disease burden of food-borne
pathogens. Case-control studies are limited in attributing human infections to the different …
pathogens. Case-control studies are limited in attributing human infections to the different …
Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children Register
…, MAJ Van Rossum, JM van den Berg… - …, 2013 - academic.oup.com
Objective. Because TNF inhibitors are not approved for persistent oligoarticular JIA (oJIA),
although they are used off-label, we evaluated their effectiveness in patients in this category. …
although they are used off-label, we evaluated their effectiveness in patients in this category. …
Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC Register
…, MAJ van Rossum, LWA van Suijlekom-Smit - Annals of the …, 2013 - ard.bmj.com
Objective To evaluate the effectiveness and safety of switching to a second or third biological
agent in juvenile idiopathic arthritis (JIA) after etanercept failure. Methods The Arthritis and …
agent in juvenile idiopathic arthritis (JIA) after etanercept failure. Methods The Arthritis and …
Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register
…, W Armbrust, SL Gorter, PA van Pelt… - Annals of the …, 2015 - ard.bmj.com
… Joost F Swart2, … J Merlijn van den Berg8, … 7 Department of Pediatrics/Pediatric
Rheumatology, St Lucas Andreas Hospital and Reade Institute, Amsterdam, The Netherlands …
Rheumatology, St Lucas Andreas Hospital and Reade Institute, Amsterdam, The Netherlands …